Endoscopic Biliary Drainage Versus Percutaneous Transhepatic Biliary Drainage in Patients with Resectable Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis.

BACKGROUND Hilar cholangiocarcinoma (HCCA) is a rare tumor, usually associated with obstructive jaundice and unfavorable prognosis. Obstructive jaundice can affect the liver, kidney, heart, and the immune system of the patients. Currently, controversy exists in whether preoperative biliary drainage (PBD) is of any benefit to the patients, and the best way for PBD in patients with resectable HCCA of malignant biliary obstruction remains to be determined. OBJECTIVES To compare the clinical outcomes and effectiveness of endoscopic biliary drainage (EBD) treatment with those of percutaneous transhepatic biliary drainage (PTBD) treatment in patients with malignant biliary obstruction caused by resectable HCCA. MATERIALS AND METHODS The databases including MEDLINE, EMBASE, PubMed, CBM (China Biological Medicine Database), and CNKI were employed to identify the clinic trials on EBD versus PTBD for malignant biliary obstruction associated with resectable HCCA from January 2008 to October 2017. A systematic review and meta-analysis were carried out. RESULTS Six trials were identified and included in this study. Overall, the differences in technical success rate, R0 resection, incidence of total complication after resection, postoperative hospitalization time, resection time, and recurrence were not statistically significant between the EBD group and PTBD group (all P > .05). However, the incidence of total complications after EBD treatment is higher than that after PTBD treatment (P < .05). CONCLUSION For patients with obstructive jaundice associated with HCCA, current evidence indicate no superiority of PTBD over EBD regarding clinical feasibility and success rate, but data suggest a better clinical safety of PTBD compared with EBD in short-term postoperation. In long-term evaluation, the differences in clinical outcomes are not statistically significant between PTBD and EBD.

[1]  J. Vauthey,et al.  Hilar cholangiocarcinoma: expert consensus statement. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[2]  D. Gouma,et al.  Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases , 2015, Annals of Surgical Oncology.

[3]  J. K. Lee,et al.  A Comparison of Preoperative Biliary Drainage Methods for Perihilar Cholangiocarcinoma: Endoscopic versus Percutaneous Transhepatic Biliary Drainage , 2015, Gut and liver.

[4]  K. Gurusamy,et al.  Meta‐analysis of randomized clinical trials on safety and efficacy of biliary drainage before surgery for obstructive jaundice , 2013, The British journal of surgery.

[5]  Bo Li,et al.  Preoperative Biliary Drainage Before Resection for Hilar Cholangiocarcinoma: Whether or Not? A Systematic Review , 2011, Digestive Diseases and Sciences.

[6]  M. Asaka,et al.  Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma , 2011, Journal of Gastroenterology.

[7]  O. Byass,et al.  Interventional radiology in the management of malignant biliary obstruction. , 2010, World journal of gastrointestinal oncology.

[8]  D. Gouma,et al.  Endoscopic and Percutaneous Preoperative Biliary Drainage in Patients with Suspected Hilar Cholangiocarcinoma , 2009, Journal of Gastrointestinal Surgery.

[9]  J. Lameris,et al.  Percutaneous drainage and stenting for palliation of malignant bile duct obstruction , 2008, European Radiology.

[10]  M. Nagino,et al.  “Anatomic” Right Hepatic Trisectionectomy (Extended Right Hepatectomy) With Caudate Lobectomy for Hilar Cholangiocarcinoma , 2006, Annals of surgery.

[11]  W. Jarnagin,et al.  Hilar cholangiocarcinoma: diagnosis and staging. , 2005, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[12]  M. Nagino,et al.  Bacteremia after hepatectomy: an analysis of a single-center, 10-year experience with 407 patients , 2002, Langenbeck's Archives of Surgery.

[13]  W. Bechstein,et al.  Extended resections for hilar cholangiocarcinoma. , 1999, Annals of surgery.

[14]  S. Kawasaki,et al.  Outcome of extended right hepatectomy after biliary drainage in hilar bile duct cancer. , 1995, Archives of surgery.

[15]  J. Vauthey,et al.  Recent Advances in the Management of Cholangiocarcinomas , 1994, Seminars in liver disease.

[16]  S. Duffy,et al.  Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. , 1983, Gut.

[17]  S. Blamey,et al.  Prediction of risk in biliary surgery , 1983, The British journal of surgery.

[18]  K. Okuda,et al.  Percutaneous transhepatic drainage of the biliary tract: Technique and results in 104 cases , 1978 .

[19]  G. Klatskin.  ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES. , 1965, The American journal of medicine.

[20]  M. Chung,et al.  Best options for preoperative biliary drainage in patients with Klatskin tumors , 2016, Surgical Endoscopy.

[21]  S. Gallinger,et al.  Endoscopic or percutaneous biliary drainage for Klatskin tumors? , 2013, Journal of vascular and interventional radiology : JVIR.

[22]  C. Yoon,et al.  Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. , 2009, Gastrointestinal endoscopy.

[23]  T. Takada,et al.  Percutaneous transhepatic cholangial drainage: Direct approach under fluoroscopic control , 1976, Journal of surgical oncology.